Logo image of CRNA.OL

CIRCIO HOLDING (CRNA.OL) Stock Overview

OSL:CRNA - NO0013033795 - Common Stock

0.606 NOK
+0 (+0.66%)
Last: 9/5/2025, 7:00:00 PM

CRNA.OL Key Statistics, Chart & Performance

Key Statistics
52 Week High3.31
52 Week Low0.48
Market Cap63.94M
Shares105.51M
Float70.99M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)2.79
PE0.22
Fwd PEN/A
Earnings (Next)N/A N/A
IPO06-16 2014-06-16
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


CRNA.OL short term performance overview.The bars show the price performance of CRNA.OL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -2 -4 -6 -8 -10

CRNA.OL long term performance overview.The bars show the price performance of CRNA.OL in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 40 -40 60

The current stock price of CRNA.OL is 0.606 NOK. In the past month the price decreased by -3.5%. In the past year, price decreased by -45.65%.

CIRCIO HOLDING / CRNA Daily stock chart

CRNA.OL Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
4AB.DE ABBVIE INC 20 319.75B
AMG.DE AMGEN INC 12.9 129.53B
GIS.DE GILEAD SCIENCES INC 14.8 121.55B
VX1.DE VERTEX PHARMACEUTICALS INC 23.26 86.34B
ARGX.BR ARGENX SE 87.74 39.68B
22UA.DE BIONTECH SE-ADR N/A 21.35B
IDP.DE BIOGEN INC 8.88 17.81B
1MRNA.MI MODERNA INC N/A 8.26B
0QF.DE MODERNA INC N/A 8.05B
1EXAS.MI EXACT SCIENCES CORP N/A 7.29B
ABVX.PA ABIVAX SA N/A 5.69B
1VKTX.MI VIKING THERAPEUTICS INC N/A 2.59B

About CRNA.OL

Company Profile

CRNA logo image Circio Holding ASA is a biotechnology company, which engages in developing novel circular RNA and immunotherapy medicines. The company is headquartered in Lysaker, Akershus. The company went IPO on 2014-06-16. The firm is engaged in the biotechnology and develops ribonucleic acid (RNA) and immunotherapy medicines. The firm offers circular RNA (circRNA) platform to develop circRNA medicines for cancer, vaccines, protein replacement for genetic disorders and cell therapy. The circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA-based vectors that can be deployed for multiple purposes. Circios strategy is to develop circAde cancer medicines in-house and seek partnerships in other therapeutic areas to demonstrate the broad potential of the circVec platform and accelerate circRNA pipeline development. Circio’s second clinical program is an immunotherapy targeting KRAS driver mutations.

Company Info

CIRCIO HOLDING

Vollsveien 19

Lysaker AKERSHUS NO

Employees: 9

CRNA Company Website

CRNA Investor Relations

Phone: 4721398810

CIRCIO HOLDING / CRNA.OL FAQ

What is the stock price of CIRCIO HOLDING today?

The current stock price of CRNA.OL is 0.606 NOK. The price increased by 0.66% in the last trading session.


What is the ticker symbol for CIRCIO HOLDING stock?

The exchange symbol of CIRCIO HOLDING is CRNA and it is listed on the Euronext Oslo exchange.


On which exchange is CRNA.OL stock listed?

CRNA.OL stock is listed on the Euronext Oslo exchange.


What is the price forecast or stock price prediction for CIRCIO HOLDING stock?

7 analysts have analysed CRNA.OL and the average price target is 3.06 NOK. This implies a price increase of 404.95% is expected in the next year compared to the current price of 0.606. Check the CIRCIO HOLDING stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is CIRCIO HOLDING worth?

CIRCIO HOLDING (CRNA.OL) has a market capitalization of 63.94M NOK. This makes CRNA.OL a Micro Cap stock.


How many employees does CIRCIO HOLDING have?

CIRCIO HOLDING (CRNA.OL) currently has 9 employees.


What are the support and resistance levels for CIRCIO HOLDING (CRNA.OL) stock?

CIRCIO HOLDING (CRNA.OL) has a support level at 0.59 and a resistance level at 0.61. Check the full technical report for a detailed analysis of CRNA.OL support and resistance levels.


Is CIRCIO HOLDING (CRNA.OL) expected to grow?

The Revenue of CIRCIO HOLDING (CRNA.OL) is expected to decline by -25.6% in the next year. Check the estimates tab for more information on the CRNA.OL EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy CIRCIO HOLDING (CRNA.OL) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does CIRCIO HOLDING (CRNA.OL) stock pay dividends?

CRNA.OL does not pay a dividend.


What is the Price/Earnings (PE) ratio of CIRCIO HOLDING (CRNA.OL)?

The PE ratio for CIRCIO HOLDING (CRNA.OL) is 0.22. This is based on the reported non-GAAP earnings per share of 2.79 and the current share price of 0.606 NOK. Check the full fundamental report for a full analysis of the valuation metrics for CRNA.OL.


CRNA.OL Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

CRNA.OL Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to CRNA.OL. CRNA.OL may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CRNA.OL Financial Highlights

Over the last trailing twelve months CRNA.OL reported a non-GAAP Earnings per Share(EPS) of 2.79. The EPS increased by 117.43% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA 451.2%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-104.92%
Sales Q2Q%N/A
EPS 1Y (TTM)117.43%
Revenue 1Y (TTM)-100%

CRNA.OL Forecast & Estimates

7 analysts have analysed CRNA.OL and the average price target is 3.06 NOK. This implies a price increase of 404.95% is expected in the next year compared to the current price of 0.606.

For the next year, analysts expect an EPS growth of -183.35% and a revenue growth -25.6% for CRNA.OL


Analysts
Analysts85.71
Price Target3.06 (404.95%)
EPS Next Y-183.35%
Revenue Next Year-25.6%

CRNA.OL Ownership

Ownership
Inst Owners0.16%
Ins Owners14.33%
Short Float %N/A
Short RatioN/A